Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

13.16
+0.58004.61%
Volume:2.79M
Turnover:37.58M
Market Cap:1.87B
PE:-3.40
High:13.79
Open:13.51
Low:13.02
Close:12.58
52wk High:46.81
52wk Low:6.36
Shares:142.26M
Float Shares:118.00M
Volume Ratio:1.74
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8694
EPS(LYR):-3.3716
ROE:-61.32%
ROA:-35.45%
PB:3.28
PE(LYR):-3.90

Loading ...

Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jul 28, 2025

Major Issues Report

Form 8-K - Current report
Jul 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities